Dr. William J. Devan, MD

Dr. Devan practices at South Shore Hospital in South Weymouth, Massachusetts, part of South Shore Health System.

Dr. Devan's NPI, 1902338361, was assigned on April 3, 2017. Dr. Devan graduated from Tufts University School of Medicine in 2017. Dr. Devan holds Massachusetts license 292124.

Dr. Devan's primary practice is South Shore Hospital, at 55 Fogg Road, South Weymouth, MA 02190 in Norfolk County. The practice phone is (781) 340-8000.

Dr. Devan's primary practice is South Shore Hospital in South Weymouth, Massachusetts, part of South Shore Health System. Dr. Devan is also affiliated with Beth Israel Deaconess Hospital-Plymouth. The medical group on file is South Shore Medical Center. Dmand AI also links Dr. Devan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devan practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Devan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Devan is licensed in Massachusetts.

CMS data shows 5,430 Medicare services from Dr. Devan across 32 procedure codes in 2024, for 684 Medicare patients. Medicare paid $190,031 for them.

CMS counts 684 Medicare patients who saw Dr. Devan in 2024. The largest group is 75 to 84, with 288 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devan's median patient age at 66, with 30% women.

In 2024, Dr. Devan wrote 1,761 Medicare Part D claims for 441 patients. 79% of them were for generic drugs. CMS names the drug for 1,636 of them, across 24 drugs with 11 or more claims each, at $241,903 in total drug cost. In 2023, CMS named 1,156 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Devan for performance year 2024, reported as part of a group. Dr. Devan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devan as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Devan, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Dr. Devan, published from 2010 to 2022. 2013 was the busiest year, with 5. The most frequent topics are Genetic Predisposition to Disease, Genome-Wide Association Study and Polymorphism, Single Nucleotide. Dr. Devan has published most often in Stroke. Dr. Devan's most frequent co-authors are James F. Meschia, MD, Natalia Sana Rost, MD and Bradford Burke Worrall, MD.

CMS Open Payments shows 5 general payments to Dr. Devan from 4 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Terumo Medical Corporation paid the most, $134.

Dr. Devan graduated from Tufts University School of Medicine in 2017.